Albert Bourla's tweet - "Emergency uses of the Bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+. See Fact Sheets: "

Today, the EMA CHMP adopted a positive opinion recommending our Omicron BA.1-adapted #COVID19 vaccine booster, potentially providing Europeans with another solution to address the ongoing challenges of this disease: on.pfizer.com/3R6NT2p

Albert Bourla

@AlbertBourla | 58,047 followers

Replying to @AlbertBourla

Emergency uses of the Bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+. See Fact Sheets: cvdvaccine-us.com

Tweet Engagement Stats

Stats are based upon replies and quotes of this tweet

Top Applications	%
twitter.com Twitter for Android · twitter.com/download/android	60.0%
mobile.twitter.com Twitter Web App · mobile.twitter.com	20.0%
twitter.com Twitter for iPad · twitter.com/#!/download/ipad	20.0%

Top Content Types	%
URL	40.0%
Photo	20.0%

Engagement Map

Quotes

Replies

Retweets

Replies and Quotes

Total of 5 replies and 2 quotes found

In reply to @AlbertBourla

PatientBuddy

@nikyak_buddy

Imagen you are 12+ and you parents decide you to protect with vaccine wich was tested on 8 mouses.. With no biodistribution, genotoxcity, cancrogenic studies would you be happy?

Verónica Carbayona

@cavronica

Tócate los 🥚🥚
¿Hace honor al apellido,eh?

In reply to @AlbertBourla

Satirical Scientist 🚜

@SatireScience

Surely their isn't new data to hide for 75 years?

In reply to @AlbertBourla

workingartwork

@workingartwork

You put profit over people. People are learning how you lie and exploit them. pic.twitter.com/K6ZqGrpoFF

In reply to @DaniWolv

Verónica Carbayona

@cavronica

Y éste te dice en la cara lo que hay sin despeinarse. twitter.com/AlbertBourla/s…

Over 2 replies and quotes not shown

Retweeters

3 retweeters not shown

For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.

Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.

Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.